320 related articles for article (PubMed ID: 26607552)
1. Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models.
Mendioroz M; Do C; Jiang X; Liu C; Darbary HK; Lang CF; Lin J; Thomas A; Abu-Amero S; Stanier P; Temkin A; Yale A; Liu MM; Li Y; Salas M; Kerkel K; Capone G; Silverman W; Yu YE; Moore G; Wegiel J; Tycko B
Genome Biol; 2015 Nov; 16():263. PubMed ID: 26607552
[TBL] [Abstract][Full Text] [Related]
2. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models.
Do C; Xing Z; Yu YE; Tycko B
Epigenomics; 2017 Feb; 9(2):189-207. PubMed ID: 27911079
[TBL] [Abstract][Full Text] [Related]
3. Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndrome.
Cejas RB; Wang J; Hageman-Blair R; Liu S; Blanco JG
Gene; 2021 Jan; 764():145099. PubMed ID: 32861879
[TBL] [Abstract][Full Text] [Related]
4. Whole genome bisulfite sequencing of Down syndrome brain reveals regional DNA hypermethylation and novel disorder insights.
Laufer BI; Hwang H; Vogel Ciernia A; Mordaunt CE; LaSalle JM
Epigenetics; 2019 Jul; 14(7):672-684. PubMed ID: 31010359
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.
Yu YE; Xing Z; Do C; Pao A; Lee EJ; Krinsky-McHale S; Silverman W; Schupf N; Tycko B
Prog Brain Res; 2020; 251():1-28. PubMed ID: 32057305
[TBL] [Abstract][Full Text] [Related]
7. Global DNA hypermethylation in down syndrome placenta.
Jin S; Lee YK; Lim YC; Zheng Z; Lin XM; Ng DP; Holbrook JD; Law HY; Kwek KY; Yeo GS; Ding C
PLoS Genet; 2013 Jun; 9(6):e1003515. PubMed ID: 23754950
[TBL] [Abstract][Full Text] [Related]
8. Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome.
Jones MJ; Farré P; McEwen LM; Macisaac JL; Watt K; Neumann SM; Emberly E; Cynader MS; Virji-Babul N; Kobor MS
BMC Med Genomics; 2013 Dec; 6():58. PubMed ID: 24373378
[TBL] [Abstract][Full Text] [Related]
9. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing.
Lim JH; Kang YJ; Lee BY; Han YJ; Chung JH; Kim MY; Kim MH; Kim JW; Cho YH; Ryu HM
Clin Epigenetics; 2019 Dec; 11(1):180. PubMed ID: 31801612
[TBL] [Abstract][Full Text] [Related]
10. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.
Lu J; Mccarter M; Lian G; Esposito G; Capoccia E; Delli-Bovi LC; Hecht J; Sheen V
Hum Mol Genet; 2016 May; 25(9):1714-27. PubMed ID: 26911678
[TBL] [Abstract][Full Text] [Related]
11. A unique downregulation of h2-calponin gene expression in Down syndrome: a possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21.
Kuromitsu J; Yamashita H; Kataoka H; Takahara T; Muramatsu M; Sekine T; Okamoto N; Furuichi Y; Hayashizaki Y
Mol Cell Biol; 1997 Feb; 17(2):707-12. PubMed ID: 9001224
[TBL] [Abstract][Full Text] [Related]
12. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation in the developing Down syndrome cortex.
El Hajj N; Dittrich M; Böck J; Kraus TF; Nanda I; Müller T; Seidmann L; Tralau T; Galetzka D; Schneider E; Haaf T
Epigenetics; 2016 Aug; 11(8):563-78. PubMed ID: 27245352
[TBL] [Abstract][Full Text] [Related]
14. Altered DNA methylation in leukocytes with trisomy 21.
Kerkel K; Schupf N; Hatta K; Pang D; Salas M; Kratz A; Minden M; Murty V; Zigman WB; Mayeux RP; Jenkins EC; Torkamani A; Schork NJ; Silverman W; Croy BA; Tycko B
PLoS Genet; 2010 Nov; 6(11):e1001212. PubMed ID: 21124956
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density.
Lim JH; Lee DE; Kim KS; Kim HJ; Lee BY; Park SY; Ahn HK; Lee SW; Kim MY; Ryu HM
Clin Chem Lab Med; 2014 May; 52(5):641-7. PubMed ID: 24353143
[TBL] [Abstract][Full Text] [Related]
16. Down Syndrome Altered Cell Composition in Blood, Brain, and Buccal Swab Samples Profiled by DNA-Methylation-Based Cell-Type Deconvolution.
Zhang Z; Stolrow HG; Christensen BC; Salas LA
Cells; 2023 Apr; 12(8):. PubMed ID: 37190077
[TBL] [Abstract][Full Text] [Related]
17. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies.
Papageorgiou EA; Fiegler H; Rakyan V; Beck S; Hulten M; Lamnissou K; Carter NP; Patsalis PC
Am J Pathol; 2009 May; 174(5):1609-18. PubMed ID: 19349366
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.
Lim JH; Kim SY; Park SY; Lee SY; Kim MJ; Han YJ; Lee SW; Chung JH; Kim MY; Yang JH; Ryu HM
PLoS One; 2011; 6(11):e27709. PubMed ID: 22132128
[TBL] [Abstract][Full Text] [Related]
19. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
[TBL] [Abstract][Full Text] [Related]
20. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
